Dual recognition of phosphoserine and phosphotyrosine in histone variant H2A.X by DNA damage response protein MCPH1

Namit Singh(Mayo Clinic), Harihar Basnet(Howard Hughes Medical Institute), Timothy D. Wiltshire(Mayo Clinic), Duaa H. Mohammad(Massachusetts Institute of Technology), James R. Thompson(Mayo Clinic), A. Héroux(Brookhaven National Laboratory), Maria Victoria Botuyan(Mayo Clinic), Michael B. Yaffe(Massachusetts Institute of Technology), Fergus J. Couch(Emory University Hospital), Michael G. Rosenfeld(Howard Hughes Medical Institute), Georges Mer
Proceedings of the National Academy of Sciences
August 20, 2012
Cited by 64Open Access
Full Text

Abstract

Tyr142, the C-terminal amino acid of histone variant H2A.X is phosphorylated by WSTF (Williams-Beuren syndrome transcription factor), a component of the WICH complex (WSTF-ISWI chromatin-remodeling complex), under basal conditions in the cell. In response to DNA double-strand breaks (DSBs), H2A.X is instantaneously phosphorylated at Ser139 by the kinases ATM and ATR and is progressively dephosphorylated at Tyr142 by the Eya1 and Eya3 tyrosine phosphatases, resulting in a temporal switch from a postulated diphosphorylated (pSer139, pTyr142) to monophosphorylated (pSer139) H2A.X state. How mediator proteins interpret these two signals remains a question of fundamental interest. We provide structural, biochemical, and cellular evidence that Microcephalin (MCPH1), an early DNA damage response protein, can read both modifications via its tandem BRCA1 C-terminal (BRCT) domains, thereby emerging as a versatile sensor of H2A.X phosphorylation marks. We show that MCPH1 recruitment to sites of DNA damage is linked to both states of H2A.X.


Related Papers

No related papers found

Powered by citation graph analysis